Description
Elamipretide (also designated SS-31 or MTP-131) is a synthetic tetrapeptide belonging to the Szeto-Schiller class of mitochondria-targeting compounds. Its sequence alternates aromatic and basic amino acid residues, a structural arrangement that confers a strong positive charge at physiological pH and enables the molecule to concentrate within the inner mitochondrial membrane independently of membrane potential [1]. Researchers studying subcellular compartmentalization and mitochondrial bioenergetics select this compound precisely because of that targeted uptake profile.
A defining structural feature of elamipretide is its selective affinity for cardiolipin, a dimeric phospholipid found almost exclusively in the inner mitochondrial membrane. Cardiolipin plays an organizational role in anchoring the electron transport chain complexes and maintaining cristae architecture; experimental disruption of cardiolipin stability is widely used to model mitochondrial membrane dysfunction. By binding cardiolipin, elamipretide has become a tool for investigating how inner-membrane integrity relates to electron transport chain efficiency and ATP production [1].
A second area of investigative focus involves the compound's influence on reactive oxygen species (ROS) generated at the mitochondrial level. Because elamipretide acts at the site of mitochondrial ROS production rather than functioning as a bulk-phase antioxidant, it has been applied in preclinical models to probe the mechanistic relationship between oxidative stress, mitochondrial membrane condition, and downstream cellular signaling — including neuroinflammatory and synaptic pathways studied in rodent models [3]. This mechanistic specificity distinguishes it from broader antioxidant tools available to researchers.
Elamipretide is commonly prepared as a lyophilized, endotoxin-controlled powder to support use in sensitive cell-based and tissue-based experimental systems where contaminant-driven confounds would compromise data interpretation. Its activity has been investigated across a range of preclinical contexts, from models of oxidative stress and neuroinflammation to assessments of mitochondrial bioenergetics, making it a widely referenced compound in the mitochondrial biology research literature [1] [3].
---
References
[1] Elamipretide: A Review of Its Structure, Mechanism of Action, and Therapeutic Potential. International Journal of Molecular Sciences, 2025. https://pubmed.ncbi.nlm.nih.gov/39940712/
[3] Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice. Journal of Neuroinflammation, 2019. https://pubmed.ncbi.nlm.nih.gov/31747905/
